Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate for early postoperative cognitive dysfunction after laparoscopic colorectal cancer surgery in elderly patients
ChiCTR2400092987Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of Jiangnan University
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of magnesium sulfate in post-operative cognitive decline (POCD) (2 arms), sponsored by Affiliated Hospital of Jiangnan University. Primary endpoint: Incidence of postoperative cognitive dysfunction. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
magnesium sulfate
03
Conditions
post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on ChiCTR2400092987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400092987.